Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
glucose metabolism
|
| gptkbp:alsoKnownAs |
adult-onset diabetes
non-insulin-dependent diabetes mellitus |
| gptkbp:cause |
hyperglycemia
hypoglycemia (if treated with insulin or sulfonylureas) |
| gptkbp:characterizedBy |
insulin resistance
relative insulin deficiency |
| gptkbp:complication |
gptkb:cardiovascular_disease
stroke kidney failure peripheral neuropathy amputation retinopathy foot ulcers |
| gptkbp:diagnosedBy |
gptkb:oral_glucose_tolerance_test
HbA1c test fasting blood glucose test |
| gptkbp:firstDescribed |
20th century
|
| gptkbp:hasGeneticComponent |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
type 2 diabetes
|
| gptkbp:ICD-10_code |
E11
|
| gptkbp:managedBy |
endocrinologist
primary care physician |
| gptkbp:onset |
usually adulthood
|
| gptkbp:prevalence |
high worldwide
|
| gptkbp:prevention |
weight management
healthy diet regular exercise |
| gptkbp:relatedTo |
gptkb:gestational_diabetes
type 1 diabetes |
| gptkbp:riskFactor |
age
family history obesity hypertension ethnicity physical inactivity dyslipidemia |
| gptkbp:symptom |
fatigue
blurred vision frequent urination increased thirst slow-healing wounds |
| gptkbp:treatment |
gptkb:metformin
gptkb:insulin gptkb:GLP-1_receptor_agonists gptkb:SGLT2_inhibitors lifestyle modification oral hypoglycemic agents sulfonylureas |
| gptkbp:bfsParent |
gptkb:diabetes
gptkb:diabetes_mellitus gptkb:polycystic_ovary_syndrome gptkb:Starlix |
| gptkbp:bfsLayer |
5
|